external anus genitals wart
Conditions
Interventions
Group A: Glicigen+Viusid Glicigen: For 3 to 5 daily application (dependent of the lesion skin size) beetewn 5 days to 8 weeks according to the clinical evolution. There will be topical application (sp
Sponsors
Catálysis S.L.
Eligibility
Sex/Gender
All
Age
6 Years to 18 Years
Inclusion criteria
Inclusion criteria: Patient with lesions characteristic and diagnostic of (externalanus genitals warts) To be included beetwen 6 and 18 years old of both sexes.(Identify Card) Signed informed consent Negative VDRL, Hepatitis B Antigen and HIV diagnostic test
Exclusion criteria
Exclusion criteria: With previous treatment Pregnant Patients taking steroides, inmunomodulates and topic and sistemic antivirals therapy Patient that refer manifestations of high sensibility to the medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disappearance of the lesions (Excellent, Good, Regular, Bad). Measurement time: 2, 4, 6,and 8 weeks after treatment. Excellent (E): Disappearance of the lesions in less than 2 Weeks of initiated the treatment Good (B): Disappearance of the lesions between 2 and 5 weeks of initiated the treatment Regular (R): Disappearance of the lesions between 6 and 8 weeks of initiated the treatment Bad (M) Not Disappearance of the lesions after 8 weeks of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of the number of the lesions (Excellent, Good, Regular, Bad).Measurement time: 8 weeks after treatment. Excellent (E) Disappearance of the lesions or reduction equal or more than 75 % Good (B) Reduction between 50 % and less than 75% Regular (R): Reduction less than less than 50 % and more than 25% Bad (M): Reduction equal or less than 25% Appearance of the lesion (flats, papilomatouse): (Good, Regular, Bad). Measurement time: 8 weeks after treatment. Good. Disappearance of the lesion Regular: Changes the appearance from papilomatouse to flat Bad: When remains the same appearance or changes to papilomatouse Adverse lesions present during treatment (good, Regular, Bad). Measurement time: 8 weeks after treatment. Good: Not presents adverse lesions during treatment Regular: Presents adverse lesions but, is possible to continue the treatment Bad: Presents adverse lesions and Is not possible to continue the treatment | — |
Countries
Cuba
Contacts
Public ContactEdelisa Moredo
Juan Manuel Márquez Pediatric Educational Hospital
Outcome results
None listed